Literature DB >> 19063661

Scaffold-free human cardiac tissue patch created from embryonic stem cells.

Kelly R Stevens1, Lil Pabon, Veronica Muskheli, Charles E Murry.   

Abstract

Progress in cardiac tissue engineering has been limited by (1) unfavorable cell and host responses to biomaterial scaffolds, (2) lack of suitable human cardiomyocyte sources, and (3) lack of fabrication techniques for scalable production of engineered tissue constructs. Here we report a novel and scalable method to generate scaffold-free human cardiac tissue patches. Human embryonic stem cells were differentiated to cardiomyocytes using activin A and BMP4 and placed into suspension on a rotating orbital shaker. Cells aggregated to form macroscopic disc-shaped patches of beating tissue after 2 days. Patch diameter was directly proportional to input cell number (approximately 11 mm with 12 million cells), and patches were 300-600 mum thick. Cardiomyocytes were concentrated around the patch edges and exhibited increased purity and maturation with time, comprising approximately 80% of total cells after 11 days. Noncardiac cell elements, primarily epithelium, were present at day 2 but were diminished markedly at later time points. Cardiomyocyte proliferation occurred throughout the patches at day 2 but declined by day 8. Patches exhibited automaticity and synchronous calcium transients, indicating electromechanical coupling. These novel scaffold-free human myocardial patches address critical challenges related to human cell sourcing and tissue fabrication that previously inhibited progress in cardiac tissue engineering.

Entities:  

Mesh:

Year:  2009        PMID: 19063661      PMCID: PMC2774496          DOI: 10.1089/ten.tea.2008.0151

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  46 in total

1.  Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle.

Authors:  Hiroshi Naito; Ivan Melnychenko; Michael Didié; Karin Schneiderbanger; Pia Schubert; Stephan Rosenkranz; Thomas Eschenhagen; Wolfram-Hubertus Zimmermann
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

Review 2.  Regeneration gaps: observations on stem cells and cardiac repair.

Authors:  Charles E Murry; Hans Reinecke; Lil M Pabon
Journal:  J Am Coll Cardiol       Date:  2006-04-17       Impact factor: 24.094

3.  Tissue engineering of vascularized cardiac muscle from human embryonic stem cells.

Authors:  Oren Caspi; Ayelet Lesman; Yaara Basevitch; Amira Gepstein; Gil Arbel; Irit Huber Manhal Habib; Lior Gepstein; Shulamit Levenberg
Journal:  Circ Res       Date:  2007-01-11       Impact factor: 17.367

4.  Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds.

Authors:  Milica Radisic; Hyoungshin Park; Fen Chen; Johanna E Salazar-Lazzaro; Yadong Wang; Robert Dennis; Robert Langer; Lisa E Freed; Gordana Vunjak-Novakovic
Journal:  Tissue Eng       Date:  2006-08

Review 5.  Heart muscle engineering: an update on cardiac muscle replacement therapy.

Authors:  Wolfram-Hubertus Zimmermann; Michael Didié; Stephan Döker; Ivan Melnychenko; Hiroshi Naito; Christina Rogge; Malte Tiburcy; Thomas Eschenhagen
Journal:  Cardiovasc Res       Date:  2006-04-07       Impact factor: 10.787

6.  Cardiac bodies: a novel culture method for enrichment of cardiomyocytes derived from human embryonic stem cells.

Authors:  Chunhui Xu; Shailaja Police; Mohammad Hassanipour; Joseph D Gold
Journal:  Stem Cells Dev       Date:  2006-10       Impact factor: 3.272

7.  Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts.

Authors:  Wolfram-Hubertus Zimmermann; Ivan Melnychenko; Gerald Wasmeier; Michael Didié; Hiroshi Naito; Uwe Nixdorff; Andreas Hess; Lubos Budinsky; Kay Brune; Bjela Michaelis; Stefan Dhein; Alexander Schwoerer; Heimo Ehmke; Thomas Eschenhagen
Journal:  Nat Med       Date:  2006-04-02       Impact factor: 53.440

8.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts.

Authors:  Michael A Laflamme; Kent Y Chen; Anna V Naumova; Veronica Muskheli; James A Fugate; Sarah K Dupras; Hans Reinecke; Chunhui Xu; Mohammad Hassanipour; Shailaja Police; Chris O'Sullivan; Lila Collins; Yinhong Chen; Elina Minami; Edward A Gill; Shuichi Ueno; Chun Yuan; Joseph Gold; Charles E Murry
Journal:  Nat Biotechnol       Date:  2007-08-26       Impact factor: 54.908

9.  Chemical dimerization of fibroblast growth factor receptor-1 induces myoblast proliferation, increases intracardiac graft size, and reduces ventricular dilation in infarcted hearts.

Authors:  Kelly R Stevens; Marsha W Rolle; Elina Minami; Shuichi Ueno; Marilyn B Nourse; Jitka I Virag; Hans Reinecke; Charles E Murry
Journal:  Hum Gene Ther       Date:  2007-05       Impact factor: 5.695

10.  A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling.

Authors:  David Simpson; Hong Liu; Tai-Hwang Michael Fan; Robert Nerem; Samuel C Dudley
Journal:  Stem Cells       Date:  2007-05-24       Impact factor: 6.277

View more
  60 in total

Review 1.  Optimizing dynamic interactions between a cardiac patch and inflammatory host cells.

Authors:  Donald O Freytes; Laura Santambrogio; Gordana Vunjak-Novakovic
Journal:  Cells Tissues Organs       Date:  2011-10-12       Impact factor: 2.481

2.  Proangiogenic scaffolds as functional templates for cardiac tissue engineering.

Authors:  Lauran R Madden; Derek J Mortisen; Eric M Sussman; Sarah K Dupras; James A Fugate; Janet L Cuy; Kip D Hauch; Michael A Laflamme; Charles E Murry; Buddy D Ratner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

3.  Engineered fetal cardiac graft preserves its cardiomyocyte proliferation within postinfarcted myocardium and sustains cardiac function.

Authors:  Kazuro L Fujimoto; Kelly C Clause; Li J Liu; Joseph P Tinney; Shivam Verma; William R Wagner; Bradley B Keller; Kimimasa Tobita
Journal:  Tissue Eng Part A       Date:  2011-01-16       Impact factor: 3.845

4.  Developing vasculature and stroma in engineered human myocardium.

Authors:  Kareen L Kreutziger; Veronica Muskheli; Pamela Johnson; Kathleen Braun; Thomas N Wight; Charles E Murry
Journal:  Tissue Eng Part A       Date:  2011-02-02       Impact factor: 3.845

5.  Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling.

Authors:  Oscar J Abilez; Evangeline Tzatzalos; Huaxiao Yang; Ming-Tao Zhao; Gwanghyun Jung; Alexander M Zöllner; Malte Tiburcy; Johannes Riegler; Elena Matsa; Praveen Shukla; Yan Zhuge; Tony Chour; Vincent C Chen; Paul W Burridge; Ioannis Karakikes; Ellen Kuhl; Daniel Bernstein; Larry A Couture; Joseph D Gold; Wolfram H Zimmermann; Joseph C Wu
Journal:  Stem Cells       Date:  2017-11-13       Impact factor: 6.277

Review 6.  Differentiation of human embryonic stem cells to cardiomyocytes for in vitro and in vivo applications.

Authors:  Hilmar Vidarsson; Johan Hyllner; Peter Sartipy
Journal:  Stem Cell Rev Rep       Date:  2010-03       Impact factor: 5.739

Review 7.  Cardiac applications for human pluripotent stem cells.

Authors:  Yuji Shiba; Kip D Hauch; Michael A Laflamme
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 8.  Organ-on-a-chip platforms for studying drug delivery systems.

Authors:  Nupura S Bhise; João Ribas; Vijayan Manoharan; Yu Shrike Zhang; Alessandro Polini; Solange Massa; Mehmet R Dokmeci; Ali Khademhosseini
Journal:  J Control Release       Date:  2014-05-10       Impact factor: 9.776

9.  SLIT3-ROBO4 activation promotes vascular network formation in human engineered tissue and angiogenesis in vivo.

Authors:  Jonathan D Paul; Kareen L K Coulombe; Peter T Toth; Yanmin Zhang; Glenn Marsboom; Vytas P Bindokas; David W Smith; Charles E Murry; Jalees Rehman
Journal:  J Mol Cell Cardiol       Date:  2013-11       Impact factor: 5.000

10.  Biofabrication enables efficient interrogation and optimization of sequential culture of endothelial cells, fibroblasts and cardiomyocytes for formation of vascular cords in cardiac tissue engineering.

Authors:  Rohin K Iyer; Loraine L Y Chiu; Gordana Vunjak-Novakovic; Milica Radisic
Journal:  Biofabrication       Date:  2012-07-31       Impact factor: 9.954

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.